The global Cold Plasma Market was valued at USD 167.8 million in 2025 and is projected to grow from USD 191.1 million in 2026 to USD 495.9 million by 2033, registering a CAGR of 14.6% from 2026 to 2033. North America dominated the global market with the largest 40.4% revenue share in 2025, supported by advanced healthcare infrastructure, increasing adoption of non-invasive treatment technologies, and growing investments in medical innovation.

Market growth is primarily driven by the expanding use of cold plasma across healthcare, food safety, textiles, electronics, and industrial processing applications. The technology has emerged as an effective alternative to conventional sterilization and surface treatment methods because it delivers high antimicrobial efficiency without exposing sensitive materials or biological tissues to damaging heat or harsh chemicals. As industries continue to prioritize sustainable manufacturing, patient safety, and environmentally friendly processing technologies, demand for cold plasma solutions is expected to accelerate significantly.

Cold plasma, also referred to as non-equilibrium plasma, is a partially ionized gas generated by supplying energy to gases under controlled conditions. It produces reactive oxygen and nitrogen species capable of destroying bacteria, fungi, viruses, and other pathogens while preserving the integrity of surrounding materials. These unique properties have expanded its adoption across medical therapies, sterilization, wound care, food decontamination, packaging, and advanced surface modification.

Download a free sample copy of the Cold Plasma Market report to understand detailed coverage and inclusions in the final report

Research conducted by the University of Michigan demonstrated that cold plasma can eliminate up to 99% of airborne viruses within fractions of a second, highlighting its potential for respiratory healthcare applications and infection prevention. Such findings continue to strengthen interest in plasma-based therapeutic technologies across healthcare systems worldwide.

The increasing incidence of hospital-acquired infections (HAIs) is another major factor supporting market expansion. According to the World Health Organization (WHO), hundreds of millions of patients worldwide are affected by HAIs every year, resulting in prolonged hospital stays, increased treatment costs, and higher mortality rates. In the United States, the Centers for Disease Control and Prevention (CDC) estimates that approximately 1 in 31 hospital patients experiences at least one hospital-acquired infection on any given day, creating sustained demand for advanced sterilization and infection-control technologies such as cold plasma.

Technological Advancements Driving Market Growth

Continuous innovation in plasma science is expanding the commercial potential of cold plasma technology across healthcare and industrial sectors.

Modern cold plasma systems increasingly feature:

• Atmospheric pressure plasma technology
• Portable plasma treatment devices
• Precision plasma generators
• Automated sterilization systems
• AI-assisted treatment monitoring
• Advanced plasma surface modification platforms
• Energy-efficient plasma processing equipment

These technological developments improve treatment precision, operational efficiency, and scalability while reducing chemical usage, energy consumption, and environmental impact.

Emerging Industry Trend: Cold Plasma in Precision Medicine and Sustainable Manufacturing

One of the fastest-growing trends shaping the cold plasma market is its integration into precision healthcare and sustainable industrial production. Researchers are increasingly evaluating cold plasma for applications such as targeted cancer therapies, regenerative medicine, dental treatments, implant sterilization, and biofilm removal. Simultaneously, manufacturers are utilizing atmospheric cold plasma for eco-friendly surface activation, polymer treatment, packaging sterilization, and food preservation without chemical residues. As regulatory emphasis on sustainable technologies continues to increase, cold plasma is becoming a preferred solution across multiple industries.

Key Market Trends & Insights

Atmospheric Pressure Cold Plasma Leads the Market

• By pressure, the atmospheric pressure cold plasma segment accounted for 63.8% of the global market in 2025.
• The technology operates effectively under ambient conditions, eliminating the need for expensive vacuum systems while supporting diverse clinical and industrial applications.
• Growing adoption in wound care, sterilization, infection prevention, and medical device disinfection continues to strengthen segment growth.

Wound Healing Represents the Largest Application

• By application, the wound healing segment held the largest market share in 2025.
• Cold plasma accelerates tissue regeneration, promotes angiogenesis, reduces microbial contamination, and lowers infection risks, making it highly valuable for chronic wound management.
• Rising prevalence of diabetic ulcers, pressure ulcers, burns, and surgical wounds, combined with the expanding geriatric population, continues to drive demand for plasma-assisted wound therapies.

Regional Highlights

North America Maintains Market Leadership

• North America accounted for 40.4% of global revenue in 2025, making it the largest regional market.
• Strong healthcare spending, extensive clinical research, advanced hospital infrastructure, and growing regulatory acceptance of innovative medical technologies continue to support regional dominance.
• Ongoing investments in infection prevention technologies and minimally invasive treatments further strengthen market growth.

Looking for more specific insights? Customize this report to suite your business needs

United States Remains the Leading Country

• The U.S. cold plasma industry held the largest market share in 2025.
• Increasing adoption across hospitals, research institutions, biotechnology companies, and medical device manufacturers continues to position the country as a global innovation hub for cold plasma technologies.

Market Size & Forecast

• Market Size (2025): USD 167.8 Million
• Estimated Market Size (2026): USD 191.1 Million
• Projected Market Size (2033): USD 495.9 Million
• CAGR (2026–2033): 14.6%
• Largest Regional Market: North America
• Leading Country: United States

Expanding Applications Beyond Healthcare

Cold plasma technology is rapidly expanding beyond traditional medical applications into food processing, agriculture, electronics manufacturing, environmental remediation, and advanced materials engineering. In food safety, cold plasma is increasingly utilized to eliminate foodborne pathogens while preserving nutritional quality and extending product shelf life. In electronics manufacturing, plasma-based surface treatment improves adhesion, coating performance, and semiconductor fabrication efficiency.

Growing investments in sustainable industrial processing and chemical-free sterilization methods are expected to create new commercial opportunities over the coming decade. As industries seek environmentally responsible alternatives to conventional processing techniques, atmospheric cold plasma is positioned to become a critical enabling technology across multiple high-growth sectors.

Competitive Landscape

The global cold plasma market remains highly competitive, with companies focusing on technological innovation, product commercialization, strategic collaborations, and international expansion. Manufacturers continue investing heavily in research and development to improve plasma generation efficiency, treatment precision, portability, and clinical effectiveness while expanding applications across healthcare and industrial markets.

Strategic partnerships with hospitals, research organizations, and biotechnology companies are accelerating technology validation and commercial adoption. Companies are also pursuing mergers, acquisitions, and product portfolio diversification to strengthen their competitive position within the rapidly evolving plasma technology ecosystem.

Key Cold Plasma Companies

The following companies have been profiled in the global cold plasma market:

• Apyx Medical
• neoplas med GmbH
• Adtec Healthcare Limited
• terraplasma GmbH
• CINOGY System GmbH
• Plasmacure
• relyon plasma GmbH
• US Medical Innovations

Explore Grand View Horizon to see global and regional level statistics related to the Cold Plasma Market

Conclusion

The cold plasma market is poised for robust growth as healthcare providers, industrial manufacturers, and food processing companies increasingly adopt non-thermal plasma technologies for sterilization, wound healing, infection control, and sustainable surface treatment. Rising healthcare investments, increasing awareness of hospital-acquired infections, and growing demand for environmentally friendly processing technologies continue to create favorable market conditions.

Future market expansion will be supported by advances in atmospheric plasma systems, precision medicine, regenerative therapies, food safety innovations, and industrial automation. As research uncovers new therapeutic and commercial applications, cold plasma technology is expected to play an increasingly important role in improving healthcare outcomes, enhancing manufacturing efficiency, and supporting sustainable industrial development worldwide.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments
• Extended forecast timelines for long-term planning
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…